DLL4 and neoplasm: The combined treatment of CTX-009 and irinotecan on SW48 and SW620 xenograft mice showed a synergistic effect, and their combination reduced the expression of DLL4 in tumor tissue and promoted the apoptosis of tumor cells [245].